• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Letter to Editor on "A randomized, controlled, blinded, parallel-group, clinical trial to study the role of Ayurcov (AyurCoro3), a one-day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in India".致编辑的信：关于“一项随机、对照、双盲、平行组临床试验，旨在研究Ayurcov（AyurCoro3），一种为期一天的方案作为印度专用新冠医院（DCH）治疗新冠疾病辅助疗法的作用”
Complement Ther Med. 2022 Sep;68:102838. doi: 10.1016/j.ctim.2022.102838. Epub 2022 Apr 26.
2
A randomized, controlled, blinded, parallel group, clinical trial to study the role of Ayurcov (AyurCoro3), one day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in India.一项在印度专门的新冠医院（DCH）中进行的随机、对照、双盲、平行分组临床试验，旨在研究 Ayurcov（AyurCoro3）一日疗程作为 COVID-19 疾病管理辅助疗法的作用。
Complement Ther Med. 2022 Aug;67:102824. doi: 10.1016/j.ctim.2022.102824. Epub 2022 Mar 25.
3
Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.阿托伐他汀和阿司匹林作为 SARS-CoV-2 感染患者的辅助治疗：一项随机对照试验的研究方案的结构化总结。
Trials. 2020 Oct 30;21(1):902. doi: 10.1186/s13063-020-04840-y.
4
Safety and efficacy of Ayurvedic interventions and Yoga on long term effects of COVID-19: A structured summary of a study protocol for a randomized controlled trial.阿育吠陀干预和瑜伽对 COVID-19 长期影响的安全性和有效性：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jun 3;22(1):378. doi: 10.1186/s13063-021-05326-1.
5
A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.一项评价阿司匹林、阿托伐他汀和尼可地尔三联疗法在 SARS-CoV-2 感染住院患者中的疗效和安全性的随机、开放标签试验：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jul 15;22(1):451. doi: 10.1186/s13063-021-05361-y.
6
Letter to the editor: efficacy of different methods of combination regimen administrations including dexamethasone, intravenous immunoglobulin, and interferon-beta to treat critically ill COVID-19 patients: a structured summary of a study protocol for a randomized controlled trial.给编辑的信：包括地塞米松、静脉注射免疫球蛋白和干扰素-β在内的不同联合方案给药方法治疗危重症 COVID-19 患者的疗效：一项随机对照试验的研究方案的结构化总结。
Trials. 2020 Jun 19;21(1):549. doi: 10.1186/s13063-020-04499-5.
7
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
8
Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.恢复期血浆/甲磺酸卡莫司他用于早期SARS-CoV-2 Q-PCR阳性高危个体（RES-Q-HR）：一项随机对照试验研究方案的结构化总结
Trials. 2021 May 17;22(1):343. doi: 10.1186/s13063-021-05181-0.
9
Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.羟氯喹预防 SARS-CoV-2 感染和妊娠期 COVID-19 疾病严重程度的疗效和安全性（COVID-Preg）：一项随机安慰剂对照试验研究方案的结构化总结。
Trials. 2020 Jul 2;21(1):607. doi: 10.1186/s13063-020-04557-y.
10
Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.随机临床试验比较伊维菌素与安慰剂对秘鲁早期 COVID-19 患者鼻咽 PCR 转阴的疗效（SAINT-Peru）：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 9;22(1):262. doi: 10.1186/s13063-021-05236-2.

引用本文的文献

1
The construction and practice of a standardized nursing service system based on the designated hospital for the treatment of COVID-19 in China.基于中国新冠肺炎定点救治医院的标准化护理服务体系构建与实践
Arch Med Sci. 2023 Jan 13;19(1):292-297. doi: 10.5114/aoms/158550. eCollection 2023.

本文引用的文献

1
A randomized, controlled, blinded, parallel group, clinical trial to study the role of Ayurcov (AyurCoro3), one day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in India.一项在印度专门的新冠医院（DCH）中进行的随机、对照、双盲、平行分组临床试验，旨在研究 Ayurcov（AyurCoro3）一日疗程作为 COVID-19 疾病管理辅助疗法的作用。
Complement Ther Med. 2022 Aug;67:102824. doi: 10.1016/j.ctim.2022.102824. Epub 2022 Mar 25.
2
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.瑞德西韦对比标准治疗对 11 天内中症 COVID-19 患者临床状态的影响：一项随机临床试验。
JAMA. 2020 Sep 15;324(11):1048-1057. doi: 10.1001/jama.2020.16349.
3
Odds ratio vs risk ratio in randomized controlled trials.随机对照试验中的比值比与风险比
Postgrad Med. 2015 May;127(4):359-67. doi: 10.1080/00325481.2015.1022494. Epub 2015 Mar 7.

Letter to Editor on "A randomized, controlled, blinded, parallel-group, clinical trial to study the role of Ayurcov (AyurCoro3), a one-day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in India".

作者信息

Khuntia Bharat Krushna, Agarwal Aman, Sharma Gautam

机构信息

Centre for Integrative Medicine and Research (CIMR), All India Institute of Medical Sciences, New Delhi, India.

出版信息

Complement Ther Med. 2022 Sep;68:102838. doi: 10.1016/j.ctim.2022.102838. Epub 2022 Apr 26.

DOI:10.1016/j.ctim.2022.102838
PMID:35487344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9040503/
Abstract
摘要